Geode Capital Management, LLC Ngm Biopharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.17 - $1.92 $72,804 - $119,473	62,226 Added 6.75%	983,836 $1.56 Million
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.31 $20,825 - $45,468	34,709 Added 3.91%	921,610 $792,000
Q3 2023 Nov 13, 2023	BUY	$1.05 - $3.37 $37,742 - $121,134	35,945 Added 4.22%	886,901 $948,000
Q2 2023 Aug 11, 2023	BUY	$2.44 - $4.53 $146,690 - $272,339	60,119 Added 7.6%	850,956 $2.2 Million
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $156,660 - $227,410	42,113 Added 5.62%	790,837 $3.23 Million
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $38,901 - $147,505	11,408 Added 1.55%	748,724 $3.76 Million
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $109,558 - $153,764	8,702 Added 1.19%	737,316 $9.64 Million
Q2 2022 Aug 12, 2022	BUY	$10.58 - $17.5 $278,254 - $460,250	26,300 Added 3.74%	728,614 $9.34 Million
Q1 2022 May 13, 2022	BUY	$13.81 - $18.6 $59,935 - $80,724	4,340 Added 0.62%	702,314 $10.7 Million
Q4 2021 Feb 11, 2022	BUY	$17.26 - $22.02 $933,783 - $1.19 Million	54,101 Added 8.4%	697,974 $12.4 Million
Q3 2021 Nov 12, 2021	BUY	$20.15 - $26.19 $1.37 Million - $1.78 Million	68,077 Added 11.82%	643,873 $13.5 Million
Q2 2021 Aug 13, 2021	BUY	$15.06 - $30.03 $1.77 Million - $3.53 Million	117,483 Added 25.63%	575,796 $11.4 Million
Q1 2021 May 12, 2021	BUY	$24.99 - $31.93 $2.82 Million - $3.6 Million	112,796 Added 32.65%	458,313 $13.3 Million
Q4 2020 Feb 12, 2021	BUY	$16.21 - $31.44 $717,422 - $1.39 Million	44,258 Added 14.69%	345,517 $10.5 Million
Q3 2020 Nov 13, 2020	BUY	$15.59 - $19.97 $886,743 - $1.14 Million	56,879 Added 23.27%	301,259 $4.79 Million
Q2 2020 Aug 13, 2020	BUY	$11.97 - $23.47 $114,816 - $225,124	9,592 Added 4.09%	244,380 $4.82 Million
Q1 2020 May 14, 2020	BUY	$10.0 - $19.51 $476,970 - $930,568	47,697 Added 25.49%	234,788 $2.89 Million
Q4 2019 Feb 13, 2020	BUY	$9.97 - $20.28 $923,820 - $1.88 Million	92,660 Added 98.12%	187,091 $3.46 Million
Q3 2019 Nov 12, 2019	SELL	$13.09 - $18.19 $62,177 - $86,402	-4,750 Reduced 4.79%	94,431 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $1.25 Million - $1.65 Million	99,181 New	99,181 $1.45 Million

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account